UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 13, 2007
MedQuist Inc.
(Exact name of registrant as specified in its charter)
New Jersey |
| 0-19941 |
| 22-2531298 |
(State or other jurisdiction |
| (Commission |
| (I.R.S. Employer |
of incorporation) |
| File Number) |
| Identification No.) |
|
|
|
|
|
1000 Bishops Gate Blvd., Suite 300, Mt. Laurel, NJ |
| 08054 | ||
(address of principal executive offices) |
| (Zip Code) |
Registrant’s telephone number, including area code: (856) 206-4000
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01. Other Events.
MedQuist Inc. (the “Company”) announced today that on August 7, 2007 it became aware of an unsolicited “mini-tender offer” by Costa Brava Partnership III, L.P to purchase of up to 1,390,000 shares of its common stock, representing approximately 3.7% of the Company’s outstanding shares of common stock, at a price of $12.25 per share (the “Costa Brava Offer”).
The Company expresses no opinion regarding the Costa Brava Offer and is remaining neutral with respect to the Costa Brava Offer. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein solely for purposes of this Item 8.01 disclosure.
Item 9.01. Financial Statements and Exhibits.
The following exhibit is filed with this Form 8-K:
Exhibit No. |
|
|
| Description |
|
|
| ||
99.1 |
| Press Release dated August 13, 2007 |
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| MEDQUIST INC. | ||||
|
|
| |||
|
|
| |||
|
|
| |||
Date: August 13, 2007 |
| By: |
| /s/ Mark R. Sullivan | |
|
|
|
| Name: | Mark R. Sullivan |
|
|
|
| Title: | General Counsel, Chief Compliance Officer & Secretary |
2